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I. Gemmell
ax: +44 14Abstract Background: CHD, stroke and cancers are the major causes of mortality
in the UK and are responsible for significant amounts of morbidity and healthcare
costs. This study examines the proportion of CHD, stroke and cancer owing to spe-
cific risk factors in Herefordshire, UK. It estimates the population impact of a num-
ber of interventions being implemented to reduce these risk factors, through the
NHS Health Check program and the Herefordshire Health Improvement Plan. The
present study also aims to demonstrate the value of epidemiological measures in
providing evidence-based public health information in policy-making to aid decision
makers when prioritizing investments and optimal use of resources.
Methods: The epidemiological measures–Population Attributable Risk and Pop-
ulation Impact Measures–were used to assess the impact of interventions to reduce
the burden of CHD, stroke and cancer.
Results: Implementation of the NHS Health Check program will prevent 63 CHD
events, 90 MI events and 125 stroke events, and one lung cancer over a period of
5 years. Reducing specific risk factors by 5% annually through the Health Improve-
ment Plan will prevent 65 CHD events, 25 MI events, 140 stroke events, four lung2 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
2.07.002
32 347619; Fax: +44 1432
fordpct.nhs.uk (A.M. Syed),
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32 340189.
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112 A.M. Syed et al.cancer, one breast cancer and four colorectal cancer cases in Herefordshire if tar-
gets are met over a period of 5 years.
Conclusion: Physical inactivity and obesity are the major causes of CHD and
stroke events (incidence and mortality) in Herefordshire. Their impact is greater
than the combined effect of hypercholesterolemia and hypertension.
Epidemiological measures used in this study proved to be excellent tools in pro-
viding evidence-based public health information. Their use is strongly recommended
to support prioritization of primary prevention interventions.
ª 2012 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Coronary Heart Disease (CHD), stroke and cancers
are the biggest causes of death in the United King-
dom (UK) [1–3]. Together, they account for
approximately 347,000 deaths each year (191,000
cardiovascular disease [CVD] and 156,000 cancer
deaths), which are equivalent to over one-in-three
of all deaths [1,2,4]. In terms of incidence, it is
estimated that there are 300,000 new CVD events
and 297,771 new cancer cases [1,5] in the UK every
year. The social and health service costs are large
[4,6–8]. It is estimated to cost the UK economy
£30 billion annually, about half of which is due to
direct healthcare costs [9]. Therefore, CHD, stroke
and cancer prevention is a high priority in the UK.
The UK governments new white paper, ‘‘Healthy
Living, Healthy People’’ recognizes the burden of
lifestyle-related diseases such as CHD, strokes and
cancers in the UK and the urgent need to address
them [10]. The white paper outlines the govern-
ments intention to implement policies and strate-
gies in order to reduce morbidity and mortality
associated with lifestyle-driven diseases. The
National Health Services (NHS) Health Check, a
national vascular risk screening program, is one of
the featured strategies in the new white paper
[10]. It is to be offered to individuals aged
40–74 years in order to identify those at risk and
provide individually tailored advice and support to
help manage risks of heart disease, stroke and
diabetes [11]. Other strategies the white paper
highlights as important are those that positively
promote healthy behaviors and lifestyles which will
lead to a reduction in the burden of lifestyle-driven
diseases such as CHD, strokes and cancers.
In Herefordshire, an English county with a
population of 182,441, CHD, stroke and cancers
are major causes of mortality. In 2009, 51.1% of
all deaths in Herefordshire were a result of CHD,
stroke and cancer, and these diseases are responsi-
ble for 4132 years of life lost annually. CHD, stroke
and cancer also contribute to significant morbidity
in Herefordshire. In 2009, there were 7930cancer-related hospital spells (the biggest cause
of hospital admissions in Herefordshire), 999
CHD-related hospital spells and 584 cerebrovascu-
lar-related hospital spells. These conditions also
constitute a large proportion of NHS Hereford-
shires expenditure on healthcare. Overall, CHD,
stroke and cancer are responsible for 10.6% of
NHS Herefordshires total expenditure on health-
care–relatively high proportions (81.14%) of this
expenditure on secondary care.
With an aim to reduce the burden of CHD, stroke
and cancers and their cost implications, NHS Here-
fordshire plans to roll out the NHS Health Check
program and a local Health Improvement Plan:
NHS Herefordshire Health Improvement Plan (NHSH
HIP). Both of these involve in implementing pre-
vention interventions. To enable investment in
these programs and to achieve engagement across
the health and social care economy, the potential
population benefits that could be achieved in terms
of number of health events prevented and reduced
mortality such as strokes needed to be understood.
Therefore, two epidemiological tools were identi-
fied and applied: Population Attributable Risk
(PAR) and Population Impact Measures (PIMs).
PAR is defined as the proportion of disease in the
population due to a risk factor [12], while PIMs
are measures of risk and benefit for use in epidemi-
ology which can estimate the population impact of
either reduction in the prevalence of a risk factor
or improved uptake of treatment [13].
Other measures such as the quality-adjusted life
year (QALY) and the incremental cost effectiveness
ratio (ICER) are used by organizations like the
National Institute for Health and Clinical Excel-
lence (NICE) to estimate the cost-effectiveness of
interventions. However, these measures have been
criticized as they are based on aggregated individ-
ual treatment benefits and lack a local context and
population perspective [14]. In comparison, the
epidemiological measures we chose enable us to
use research data along with local data to generate
evidence-based results. The use of PARs provides
an estimate of the proportion of disease in the
Table 2 Targets used for modeling NHSH HIP.
Risk factor NHSH HIP targets
used for modeling
% reduction in
prevalence
annually (%)
Low physical activity 5
Smoking 5
Low intake of fruit & vegetables 5
Obesity 5
High alcohol consumption 5
Table 1 Annual number of individuals identified with
vascular risk factors by the NHS Health Check program in
Herefordshire using DH modeling tool.
Risk factor Number of
individuals
identified
Herefordshire
annually
Number
of individuals
identified in
Herefordshire
over 5 years
Hypercholesterolemia 720 3600
Hypertension 985 4925
Low physical activity 3295 16,475
Smoking 356 1780
Obesity 1773 8865
Total 7129 35,645
The use of epidemiological measures to estimate the impact of primary prevention 113local population. While the PIMs provide a frame-
work where local data (such as on the population
size, demographics and level of inequalities) can
be combined with the results of estimates of size
from systematic reviews and meta-analyses to esti-
mate the health gain that a local health-care orga-
nization can expect from the introduction of a new
or alternative intervention, or an increase in the
availability of an existing intervention [15].
This study examines the proportion of CHD,
stroke and cancer owing to risk factors in Hereford-
shire and the impact of planned primary prevention
interventions through the implementation of the
NHS Health Check program and the NHSH HIP, using
PAR and PIMs. More importantly, it demonstrated
the value of epidemiological measures in providing
evidence-based public health information in policy-
making and to aid decision makers when prioritiz-
ing investments and optimal use of resources.
2. Methodology
PAR and PIMs were used to assess the impact of
strategies to reduce the burden of CHD in Here-
fordshire. The two PIMs calculated in this study
are the number of events prevented in the popula-
tion (NEPP) [13] and the population impact num-
ber of eliminating (or reducing the prevalence of)
risk factor (PIN-ER-t) [16].
PAR is described as the reduction in incidence
that would be observed if the population was en-
tirely unexposed to risk factors, compared with
its current (actual) exposure pattern (e). It is cal-
culated using the population prevalence of the
exposure and the relative risk associated with the
exposure (refer to Appendix 1 for formula).
The number of events prevented in the popula-
tion (NEPP) can be used to estimate the impact
of an intervention in populations with a specified
condition. It is defined as the NEPP by an interven-
tion which reduces or eliminates a risk factor. The
calculation requires the size of the population,
the proportion of the population with the disease,
the proportion of those with the disease exposed
to the intervention, the proportion of those who
adhere to the intervention, and the reduction in
the risk of death in those receiving the intervention
compared with those not receiving the interven-
tion. The PIN-ER-t is defined as the potential num-
ber of disease events prevented in the population
over the next t years by eliminating all or a speci-
fied proportion of the risk factor [14]. It is derived
from the PAR. The calculation requires an estima-
tion of the size of the population at risk, the
incidence of the disease event in t years in the pop-
ulation, the proportion of the population exposedto the risk factor (or, for continuous variables,
the proportion with levels above the threshold),
and the relative risk of the disease event among
the exposed compared with those not exposed
[14]. Refer to Appendix 1 for PAR, NEPP and PIN-
ER-t formulae.
Information was collected from a variety of
sources to calculate the PAR and PIMs. The relative
risks (RR) and relative risk reductions (RRR) were
gathered by carrying out searches for published arti-
cles that reported relevant RR and RRR in Medline,
NHS Evidence, Cochrane and the Centre for Reviews
and Dissemination databases and the search engine
Google. RRs and RRRs were identified by reviewing
the research literature. Parameters were selected
from high level studies in line with the research
question wherever possible (Please see results
Table 3 for sources of each RR and RRR).
The PAR and PIMs were calculated for the two
planned primary prevention programs in Hereford-
shire–the NHS Health Check program and the NHSH
HIP. The NHS Health Check program aims to iden-
tify all people aged 40–74 with significant cardio-
vascular risk over a 5-year period. Using a
Department of Health (DH) modeling tool, the
number of people who would be identified annually
with particular risk factors (see Table 1) were
Table 3 Interventions, data, sources and outcome measures.
Disease Risk factors Interventions Data, sources and outcome measures
PAR PIMs
RR Prevalence of
risk factor
NHS Health Check programa NHS Health Improvement Planb
CHD Hypercholesterolemia
(>6.5 mmol/l)
Statins 2.82 36% Non-fatal MI (NEPP)
Pa = 0.80 [17], Pe = 720,
RRR = 0.42 [18], ru = 0.03 [18]
MI deaths (NEPP)
Pa = 0.80 [17], Pe = 720, RRR = 0.40
[18], ru = 0.01 [18]
N.A.
Hypertension (Systolic
BP > 145 mmHg)
Antihypertensive therapy 1.91 15.4% Non-fatal MI (NEPP)
Pa = 0.69 [19], Pe = 985,
RRR = 0.25 [20], ru = 0.02 [21]
MI deaths (NEPP)
Pa = 0.69 [21], Pe = 985,
RRR = 0.12 [20], ru = 0.01 [21]
N.A.
Smoking (>16 yrs) Smoking cessation 2.84 17.5% CHD deaths (NEPP)
Pa = 0.11 [22], Pe = 365,
RRR = 0.37 [23], ru = 0.032 [23]
CHD deaths (NEPP)
Pa = 0.11 [22], Pe = 27,317 [24],
RRR = 0.37 [23], ru = 0.032 [23]
Low intake of fruit/veg/cereal-3
or less per day
Increase consumption of
fruit and vegetables
1.16 3.54% N.A. CHD events (PINER-t)
n = 147,660, Ip = 0.0095 [25],
Pexp = 0.23 (26), RR = 1.16 [27]
Low physical activity Increase levels of physical
activity
1.6 34.81% CHD events (PINER-t)
n = 3295, Ip = 0.0095 [25],
Pexp = 1, RR = 1.6 [27]
CHD events (PINER-t)
n = 147,660, Ip = 0.0095 [25],
Pexp = 0.28 [26], RR = 1.6 [27]
Obesity (BMI > 30 kg/m2) Weight management
interventions for obese
patients
2.13 18.8% MI event (PINER-t)
n = 1773, Ip = 0.0095 [25],
Pexp = 1, RR = 1.3 [27]
MI events (PINER-t)
n = 147,660, Ip = 0.0095 [25],
Pexp = 0.228 [24], RR = 1.3 [27]
Stroke Hypercholesterolemia
(>6.5 mmol/l)
Statins 2.0 36% Non-fatal stroke events (NEPP)
Pa = 0.80 [17], Pelig = 720,
RRR = 0.80 [18}, ru = 0.00305 [18]
Stroke deaths (NEPP)
Pa = 0.80 [17], Pelig = 720,
RRR = 0.34 [18, ru = 0.02 [18]
N.A.
Hypertension (Systolic
BP > 145 mmHg)
Antihypertensive therapy 4.0 15.4% Non-fatal stroke events (NEPP)
Pa = 0.69 [19] Pelig = 985, RRR = 0.36
[20], ru = 0.01 [18]
Stroke deaths (NEPP)
Pa = 0.69 [19] Pelig = 985,
RRR = 0.36 [20], ru = 0.0031 [18]
N.A.
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Smoking Smoking cessation 1.51 17.5% Stroke events (NEPP)
Pa = 0.11 [23], Pelig = 365,
RRR = 0.36 [28], ru = 0.26 [29]
Low intake of fruit/veg/
cereal-3 or less per day
Increase consumption of
fruit and vegetables
1.26 23% (3 or less
portions per day)
N.A.
Low physical activity Increase levels of physical
activity
2.5 89% (physically
inactive)
Stroke events (PINER-t)
n = 3295, Ip = 0.00445 [30],
Pexp = 1, RR = 2.5[31]
Obesity (BMI > 30 kg/m2) Weight management
interventions for obese
patients
2.0 22.8%
(BMI > 30 kg/m2)
Stroke events (PINER-t)
n = 1773, Ip = 0.00445 [30],
Pexp = 1, RR = 2 [32]
Atrial fibrillation Increasing anticoagulation
therapy (warfarin) to
eligible patients with AF
(not done as part of any
plan- modeled as an add
on)
5.0 1.8% Stroke events (NEPP)
Pa = 0.60 [33], Pelig = 97,
RRR = 0.64 [34], ru = 0.06 [35]
Lung cancer Smoking (>16 yrs) Smoking cessation 26 18.5% Lung cancer cases(PINER-t)
n = 356, Ip = 0.000647 [30],
Pexp = 1, RR = 26 [36]
Lung cancer cases(PINER-t)
n = 147,660, Ip = 0.000647 [30],
Pexp = 0.185 [23], RR = 26 [36]
Breast cancer High alcohol consumption
(>45 g per day alcohol)
Alcohol cessation 1.46 17.7% N.A. Breast cancer cases(PINER-t)
n = 76,448, Ip = 0.0007833 [37],
Pexp = 0.177 [24], RR = 1.46 [38]
Diet (fat consumption) Advice on healthy diet 1.13 NA N.A. N.A.
Obesity (BMI > 30) Weight management
interventions for
obese patients who are
post-menopausal
1.29 NA N.A. N.A.
Colon cancer Dietary fiber intake of less
than 10 g per day
Increase intake of dietary
fiber
1.18 NA N.A. N.A.
High Alcohol consumption Alcohol cessation 1.50 17.7% N.A. Colorectal cancer cases(PINER-t)
n = 147,660, Ip = 0.000649 [37],
Pexp = 0.177[24], RR = 1.52 [39]
Obesity (BMI > 30) Weight management
interventions for obese
patients
1.19 22.8% N.A. N.A.
Smoking Smoking cessation 1.25 18.5% N.A. Colorectal cancer cases(PINER-t)
n = 147,660, Ip = 00.000649 [37],
Pexp = 0.177[24], RR = 1.27 [40]
a Pe and n used were derived using the DH tool–see Table 1; see Appendix for Pelig.
b n were derived from local demographic data.
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national assumptions of uptake assuming 20% of
the target population is called per annum and does
not take account of local implementation. As the
NHS Health Check program is over 5 years old, it
was decided to model the outcomes over a 5-year
period. Similarly, the NHS HIP target of 5% annual
reduction in prevalence for each of the risk factors
was used to model outcomes over a period of
5 years (see Table 2).
PAR in Herefordshire was calculated for the
following risk factors for CHD and stroke: high
cholesterol (>6.5 mmol/l), hypertension (systolic
BP > 145 mmHg), smoking, low intake of fruit/
veg/cereal (three or less portions per day), low
physical activity, and BMI > 30 kg/m2. In addition,
for strokes, PAR was calculated for atrial fibrilla-
tion (AF) as a risk factor. Using the NEPP and PIN-
ER-t formulas, where data were available, the
number of events or deaths prevented annually
for CHD, stroke and cancer was also calculated
for the following interventions: statin therapy,
antihypertensive therapy, smoking cessation, in-
crease in consumption of fruit and vegetables,
increase in levels of physical activity and weight
management programs for obese individuals (see
Table 3).
For cancers, only three types of cancer were ta-
ken into consideration: bronchus and lung, breast
and colorectal, as they are responsible for the most
number of deaths in Herefordshire. The PAR was
calculated for the following: smoking as a risk fac-
tor for bronchus and lung cancer; high alcohol con-
sumption (>45 g per day alcohol), diet (fat
consumption), BMI > 30 for breast cancer; and die-
tary fiber intake of less than 10 g per day, high
alcohol consumption, BMI > 30 and smoking for
colorectal cancer. The number of events and
deaths prevented over 5 years as a result of inter-
ventions aimed at these risk factors was also
calculated.
The calculations were dependent upon epide-
miological measures in the research literature.
For example, data to calculate PAR and PIMs for
cancer were difficult to find, therefore, the cal-
culations were limited for cancer in comparison
with CHD and stroke. Similarly, in some instances
measures were found of CHD events (myocardial
infarctions plus CHD deaths) while in another,
measures on myocardial infarctions (MI) alone
were found. These limitations were reflected in
the results which were expressed either as CHD
or MI events (fatal or non-fatal). In a few in-
stances modeling was not possible owing to the
lack of the necessary data for the calculations.Results of calculations where the data was avail-
able are presented below.
3. Results
The results (PAR and PIMs) are dichotomized based
on the findings for each of the three conditions.
Where PIMs are presented as events, this means a
sum of fatal and non fatal events.
3.1. Coronary Heart Disease
Table 4 summarizes the results for CHD.
The findings of this study show that hypercholes-
terolemia, which is a well-known risk factor for
CHD, is responsible for a significant proportion of
CHD in Herefordshire (39.5%). However, it was also
determined that almost as much of CHD is owing to
physical inactivity (34.8%). When coupled with
obesity, physical inactivity is responsible for over
half of the CHD in the county. It should also be
noted that another lifestyle risk factor, smoking,
causes a quarter of all CHD in the county.
It is calculated that each year the NHS Health
Check program in Herefordshire will identify 7129
individuals with CHD risk factors (see Table 1). Suc-
cessful treatment of those with risk factors will
prevent an estimated 63 CHD events and 90 MI
events over 5 years (see Table 4). It is also esti-
mated that a total of 65 CHD events and 25 MI
events would be prevented if implementation of
NHSHs HIP reduced CHD risk factors by 5% annually
in the population over 5 years (see Table 4).
3.2. Stroke
Table 5 summarizes the results for stroke.
Physical inactivity alone is responsible for over
half the cases of strokes (57.1%) in Hereford-
shire–this compares with 26.4% for hypercholes-
terolemia and 13.3% for hypertension. Similarly,
obesity (18.5%) is responsible for more strokes than
hypertension (13.3%).
It is calculated that each year the NHS Health
Check program will identify 7129 individuals with
stroke risk factors (see Table 1). Successful treat-
ment of those with risk factors will prevent an esti-
mated 125 stroke events over 5 years (see Table 5).
It is also estimated that a total of 140 stroke events
would be prevented if implementation of NHSHs
HIP reduced risk factors by 5% annually over a 5-
year period in the population (see Table 5). Fur-
ther, if anticoagulant therapy was prescribed to
all eligible AF patients, four stroke events could
be prevented (see Table 5).
Table 4 Primary prevention of CHD in Herefordshire.
Intervention Risk factor RRa Prevalence of
risk factorb(%)
PARc (%) PIMsd
Interventione Events/deaths prevented
in the cohort if targets are
achieved over 5 yearsf
NHS Health Check program Health Improvement Plan
Statins Hypercholesterolemia
(>6.5 mmol/l)
2.82 36 39.58 If 3600 individuals are
prescribed statins
N.A. 35 non-fatal MI events
15 MI deaths
Antihypertensive
therapy
Hypertension (systolic
BP > 145 mmHg)
1.91 15.4 13.34 If 4925 individuals are
prescribed antihypertensive
therapy
N.A. 15 non-fatal MI events
5 MI deaths
Smoking cessation Smoking 2.84 17.5 24.35 If 1780 individuals are given
smoking cessation
intervention
N.A. 3 CHD deaths
N.A. Decrease in number of
smokers (aged 18 years and
above) by 5% annually
10 CHD deaths
Increase
consumption of
fruit and
vegetables
Low intake of fruit/veg/
cereal-3 or less per day
1.16 23 3.54 N.A. Decrease in the number of
individuals (aged 18 years and
above) consuming 3 portions
or less of fruit or vegetable by
5% annually
10 CHD deaths
Increase levels of
physical activity
Low physical activity 1.6 89 34.81 If 16,475 individuals get
physically active
N.A. 60 CHD events
N.A. Decrease in the number of
individuals (aged 18 years and
above) who are physically
inactive by 5% annually
45 CHD events
Weight
management
interventions for
obese patients
Obesity (BMI > 30 kg/m2) 2.13 22.8 18. If 8865 individuals subjected
to weight management
interventions achieve
BMI < 27
N.A. 20 MI event
N.A. Decrease in number of
individuals (aged 18 years and
above) with BMI > 27 by 5%
annually
25 MI events
a Relative risk – The risk of CHD when exposed to the risk factors.
b Local prevalence – The proportion of the population with the risk factor in Herefordshire.
c Population Attributable Risk – The proportion of disease in the population due to the risk factor in Herefordshire.
d Population Impact Measures – the number of events prevented in the local population by treating a given number of people with the intervention (includes NEPPs and PIN-ER-ts).
e Interventions based on NHS Health Check program and NHS Herefordshire Health Improvement Plan.
f Estimated number of events/deaths which can be prevented with intervention. Unless specified, events mean fatal plus non-fatal (i.e. total events). CHD events include ALL CHD
related events.
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Table 5 Primary prevention of stroke in Herefordshire.
Intervention Risk Factor RRa Prevalence
of risk
factorb (%)
PARc (%) PIMsd
Interventione Events/deaths prevented
in the cohort if targets
are achieved over 5 yearsf
NHS Health Check program Health Improvement Plan
Statins Hypercholesterolemia
(>6.5 mmol/l)
2.0 36 26.47 If 3600 individuals are
prescribed statins
N.A. 20 non-fatal stroke events
5 stroke deaths
Antihypertensive
therapy
Hypertension
(Systolic BP > 145 mmHg)
4.0 15.4 13.39 If 4925 individuals are
prescribed antihypertensive
therapy
N.A. 10 non-fatal stroke events
5 stroke deaths
Smoking
cessation
Smoking 1.51 17.5 8.19 If 1780 individuals are given
smoking cessation
intervention
N.A. 20 stroke events
N.A. Decrease in number of smokers (aged
18 years and above) by 5% annually
70 stroke events
Increase
consumption
of fruit and
vegetables
Low intake of fruit/
veg/cereal-3 or less
per day
1.26 23 (3 or less
portions per
day)
5.64 N.A. Decrease in the number of individuals
(aged 18 years and above) consuming
3 portions or less of fruit or vegetable
by 5% annually
10 stroke events
Increase levels
of physical
activity
Low physical activity 2.5 89 (physically
inactive)
57.17 If 16,475 individuals get
physically active
45 stroke events
N.A. Decrease in the number of individuals
(aged 18 years and above) who are
physically inactive by 5% annually
35 stroke events
Weight
management
interventions for
obese patients
Obesity (BMI > 30 kg/m2) 2.0 22.8
(BMI > 30 kg/
m2)
18.5 If 8865 individuals subjected
to weight management
interventions achieve
BMI < 27
N.A. 20 stroke event
N.A. Decrease in number
of individuals (aged
18 years and above)
with BMI > 27 by 5% annually
25 stroke events
Anticoagulation
therapy
Atrial fibrillation 5.0 1.8 6.71 Increasing anticoagulation therapy
(warfarin) to eligible patients with AF
(was not done as part of either
intervention but as an additional
intervention)
4 stroke events
a Relative risk – the risk of stroke when exposed to the risk factors.
b Local prevalence – the proportion of the population with the risk factor in Herefordshire.
c Population Attributable Risk – the proportion of disease in the population due to the risk factor in Herefordshire.
d Population Impact Measures – the number of events prevented in the local population by treating a given number of people with the intervention.
e Interventions based on NHS Health Check program and NHS Herefordshire Health Improvement Plan.
f Estimated number of events/deaths which can be prevented with intervention. Unless specified, events mean fatal plus non-fatal (i.e. total events). Stroke events include ALL Stroke
related events.
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Table 6 Primary prevention of cancer in Herefordshire.
Intervention Risk factor RRa Prevalence of risk
factorb
PARc PIMsd
Interventione Events/deaths
prevented in the
cohort over 5 yearsf
NHS Health
Check program
Health Improvement Plan
Cancer of the bronchus and lungs – primary prevention
Smoking cessation Smoking 26 18.5% 81.39% If 1780
individuals quit
smoking
1 lung cancer case
N.A. If number of smokers (18 years
and above) are decreased by
5% annually
4 lung cancer cases
Breast cancer – primary prevention
Alcohol cessation High Alcohol consumption
(>45 g per day alcohol)
1.46 17.7% 7.52% N.A. If the number of binge
drinking women reduced by 5%
annually
1 breast cancer case
Advice on healthy diet Diet (fat consumption) 1.13 N.A. N.A. N.A. N.A. N.A.
Weight management interventions for
obese patients who are post-
menopausal
Obesity (BMI > 30) 1.29 N.A. N.A. N.A. N.A. N.A.
Colorectal cancer – primary prevention
Increase intake of dietary fiber Dietary fiber intake of less
than 10 g per day
1.18 N.A. N.A N.A. N.A. N.A.
Alcohol cessation High alcohol consumption 1.50 17.7% 8.27% N.A. If the number of adults
(18 years and above) who
binge drink is reduced by 5%
annually
2 colorectal cancer
cases
Weight management interventions for
obese patients
Obesity (BMI > 30) 1.19 22.8%
(BMI > 30 kg/m2)
18.56% N.A. N.A. N.A.
Smoking cessation Smoking 1.27 18.5% 4.19% N.A. If the number of smokers
(18 years and above) is
decreased by 5% annually
2 colorectal cancer
cases
a Relative risk – the risk of cancer when exposed to the risk factors.
b Local prevalence – the proportion of the population with the risk factor in Herefordshire.
c Population Attributable Risk – the proportion of disease in the population due to the risk factor in Herefordshire.
d Population Impact Measures – the number of events prevented in the local population by treating a given number of people with the intervention.
e Interventions based on NHS Health Check program and NHS Herefordshire Health Improvement Plan.
f Estimated number of events/deaths which can be prevented with intervention. Unless specified, events mean fatal plus non-fatal (i.e. total events). Stroke events include ALL Stroke
related events.
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Table 6 summarizes the results for cancer.
Although the NHS Health Check program tar-
geted reducing vascular disease, an added benefit
is that if the predicted 1780 smokers identified
over 5 years were helped to successfully quit, one
lung cancer case would be prevented.
Similarly, if implementation of the NHSHs HIP
reduces the number of smokers in Herefordshire
by 5% annually over 5 years, four lung cancer and
two colorectal cancer cases would be prevented.
Binge drinking is a well-known lifestyle risk
factor for psychological disorders and CHD. How-
ever, this study also found it contributes to 7.5%
of breast cancer and 8.2% of colorectal cancers
per annum in Herefordshire (see Table 6). If a
5% annual reduction in binge drinking over 5 years
is achieved, one breast cancer case and two
colorectal cancer cases can be prevented in
Herefordshire.
Other than being a significant risk factor for CHD
and stroke, obesity also causes 18.5% of colorectal
cancer cases in Herefordshire (see Table 6). Apply-
ing these figures to Herefordshire colorectal cancer
mortality figures, this translates into 4 colorectal
cancer deaths per annum in Herefordshire.4. Discussion
In this study, the proportion of CHD, stroke and
cancer owing to lifestyle risk factors and the num-
ber of CHD, stroke and cancer events that can be
averted in Herefordshire was calculated by rolling
the NHS Health Check program and NHSH HIP. This
study demonstrates the application of PARs in iden-
tifying the proportion of disease owing to prevent-
able risk factors and of PIMs in quantifying the
potential impact of different preventive interven-
tion on health outcomes at a local population level.
The idea that primary prevention interventions
are required to maximize population health and
minimize the economic burden of CVD is growing
[41], but emphasis is given on clinical interven-
tions. Dyslipidemia is recognized as a significant
modifiable risk factor for CVD [42], and there is
also good evidence to demonstrate the role of
hypertension as a risk factor for stroke [42]. Statin
and anti-hypertensive therapies are well recog-
nized and widely used primary preventive treat-
ment for CVD. However, in a large European
survey of physicians and patients, 95% of patients
believed they had well-controlled blood pressure
and 76% of physicians agreed, but in reality only
37% of patients achieved target blood pressure[43]. Furthermore, it has been shown that even
when risk factors such as dyslipidemia and hyper-
tension are optimally treated in clinical trials,
almost two thirds of patients still experience car-
diovascular events [44].
In the NHS, 70% of total CVD [45], 80% of CHD
[20] and 90% of diabetes [46] were attributed to
not following a low-risk lifestyle. The current find-
ings based on the PAR calculations show that in
Herefordshire, physical inactivity together with
obesity is a greater cause of CHD and stroke than
hypercholesterolemia and hypertension. This
clearly highlights the need to focus on primary pre-
vention with regard to physical inactivity and
obesity, rather than statin therapy and anti-
hypertensive therapy to reduce the burden of
CHD and stroke in Herefordshire. These findings
are in line with Endres et al. [42], which point to
the importance of lifestyle interventions as a basis
for primary prevention of CVD and primary preven-
tive actions targeting the absolute risk of cardio-
vascular diseases rather than individual risk
factors. Endres et al. [42] estimated that as much
as 70% of strokes can potentially be prevented by
a lifestyle modification in their population. Many
other studies have also shown that an overall
healthy lifestyle, such as not smoking, diet, exer-
cise and optimal body weight, may be more effec-
tive in lowering the risk of CVD and cancer, as well
as diabetes, than any one single factor [45–50].
The benefits associated with mass screening for
cardiovascular disease are unknown [51,52]. Simi-
larly, benefits of other planned primary prevention
interventions for specific populations are difficult
to determine. This study shows that PIMs are useful
in establishing the potential number of events
through planned primary prevention interventions
(NHS Health Check program and NHS HIP) for the
specific population. The results of our PIMs calcula-
tions show that the actual impact in terms of
events/deaths prevented is quite small in Here-
fordshire. Other studies in this field have also
shown that when viewed at the level of a local pop-
ulation, the impact in terms of events/deaths pre-
vented is quite small [13,27]. The study by Heller
looks at the impact in a practice population of
10,000 [13], while the study by Gemmell et al.
[27] looked at the impact in the UK, therefore
the number of events prevented was greater (only
because it is related to a larger population), but
when the results are broken down into county le-
vel, they are small.
The UK governments new white paper, ‘‘Healthy
Living, Healthy People,’’ states that the govern-
ment will end central control and give local govern-
ment the freedom, responsibility and funding to
The use of epidemiological measures to estimate the impact of primary prevention 121innovate and develop their own ways of improving
public health in their area [10]. This means that lo-
cal policy makers need relevant and local informa-
tion to underpin their resource allocation
decisions to identify diseases, risk factors, popula-
tion groups and interventions. In this study, using
PIMs, the impact of the planned primary prevention
interventions was estimated which enables re-
searchers to see the interventions that will prevent
the most number of events in the local population.
Such information can prove to be very useful to
local policy makers to make informed decisions.
Baltussen and Niessen [53] highlight the fact
that, currently, priority setting of health interven-
tions is often ad hoc and resources are not used to
an optimal extent. While Ham [54] and Robinson
[55] point out that choices may not be based on a
rational and transparent process. This study dem-
onstrates how PAR and PIMs are calculated and
how they can bring together local data and research
findings to provide the evidence base to support lo-
cal decision-making for improving population
health through primary prevention activities
eliminating ad hoc priority setting and waste of re-
sources using a rational and transparent process.
The findings from this study are inherently
dependent on the quality of the source data as
PARs and the PIMs methodology use published risk
estimates (i.e., baseline risk of disease, RR and
the RRR of the intervention of interest), which car-
ry a margin of error. Furthermore, published
sources use different definitions of disease status
and outcome and present their results over differ-
ent time-frames, age groups, and may or may not
split them by gender. To limit the risks associated
with using published sources, the parameters used
in this study were derived from systematic reviews
or meta-analyses, and whose study question
matched closest to this studys target population
and planned interventions. However, this was not
always possible owing to limitations in the avail-
ability of data in the literature, and in itself a
time-consuming and challenging process, which
could be seen as a limitation to the use of these
epidemiological measures.
Other similar studies have looked at one or two
interventions or diseases areas [14,15,17,27,56–
59]. This study is the first of its kind to use both
epidemiological measures (PARs and PIMs) to mod-
el outcomes of two complex public health pro-
grams. It included six interventions and three
disease areas. This is advantageous as it repre-
sents real life public health programs, but it is dif-
ficult to estimate the interactions between
different risk factors. Furthermore, it could not
reflect the impact of combined interventions onthe outcomes, for example weight management
and physical activity interventions will both have
an effect on the need for antihypertensive
treatment in some individuals. However, an
advantage of this study is that wherever possible,
compliance to interventions is considered, using
values derived from the literature. This does
mean that where adherence to interventions was
taken into account to model outcomes, these
values were derived from published literature.
Therefore, the outcomes are based on the
assumption that health behavior factors of the
local population are similar to the population in-
cluded in the study.
Cost-effectiveness of the interventions was not
considered in this study as it was not its primary
aim. The NHS Health Check program is a national
must-do, and the studys aim was to achieve orga-
nizational support locally to aid implementation.
However, an advantage of using the PIMs method-
ology is that a cost dimension can be introduced
to it if an economic assessment of interventions
is required by health planners. This entails a meth-
odology called population cost-impact analysis
which is described by Heller et al. [60].
5. Conclusion
The findings of this study demonstrate the popula-
tion impacts that can be achieved by implementa-
tion of primary prevention measures, through the
implementation of the NHS Health Check program
and HIP in Herefordshire. It also demonstrated that
physical inactivity and obesity levels are the most
significant causes of CHD and stroke events in
Herefordshire. Their impact is greater than the
combined effect of hypercholesterolemia and
hypertension together, both of which are well rec-
ognized and treated risk factors. These findings
should assist local decision makers when prioritiz-
ing investments and ensuring the optimal use of
resources.
The study also demonstrates the use of PARs and
PIMs in translating public health research and local
data into evidence which can be used to inform lo-
cal public health practice. The epidemiological
measures used in this study proved to be excellent
tools in providing evidence based public health
information in local policy-making and their use is
strongly recommended to support prioritization of
primary prevention interventions.Conflict of interest statement
None.
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• It is well known that Coronary Heart Disease, stroke
and cancers are responsible for significant mortality
and morbidity; their trends are on the rise both in
the UK and internationally.
• Prioritization of primary prevention interventions is
often ad hoc and the impact of planned interven-
tions is not taken into account in the planning
process.
• This study shows that physical inactivity and obesity
are responsible for more CHD and strokes than the
more recognized risk factors–hypercholesterolemia
and hypertension in Herefordshire. Further, the
impact of preventative interventions shows that
more events will be prevented by prioritizing
resources on primary prevention in comparison with
secondary prevention of hypercholesterolemia and
hypertension.
• This study also demonstrates the value of epidemi-
ological measures in providing evidence-based pub-
lic health information in local policy-making aiding
local decision makers when prioritizing investments
and the optimal use of resources in Herefordshire.
The methodology can also be used in order to sup-
port evidence-based public health policies and
practices at the national and international level.Appendix 1.
1.1. PAR
The PAR is calculated using the population preva-
lence of the exposure (Pe) and the relative risk
associated with the exposure (RR), as follows:
PAR ¼ Pe  ðRR 1Þ
½1þ PeðRR 1Þ1.2. NEPP
The number of events prevented in the population
(NEPP) to estimate the incremental change in mov-
ing from current to best practice is calculated as:
NEPP ¼ n  Pd  ðPb  PtÞ  Pa  ru  RRR
where n = population size, Pd = prevalence of dis-
ease in the population, Pb = proportion treated if
best practice was achieved, Pt = proportion cur-
rently treated, Pa = proportion who adhere to
treatment, ru = risk of the event of interest in the
untreated group or baseline risk over appropriate
time period, and RRR = relative risk reduction asso-ciated with the treatment. Please note n * Pd *
(Pb  Pt)* = number of individuals eligible for in-
tervention = Pelig.
1.3. PIN-ER-t
The PIN-ER-t estimates the number of disease
events prevented by eliminating the proportion of
a risk factor above a certain threshold; it is calcu-
lated by subtracting the PIN-ER-t obtained for the
new exposure prevalence from the PIN-ER-t for
the previous exposure prevalence (for example,
24% of population smoking PIN-ER-t subtracted
from 28% of population smoking). The PIN-ER-t is
calculated as:
PIN-ER-t ¼ n  Ip  PexpðRR 1Þ
1þ PexpðRR 1Þ
where n = population size, Pexp = prevalence of the
exposure in the population, Ip = incidence of the
outcome in the population, and RR = relative risk
of the outcome if the risk factor is present.
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